PULSE the living trend engine
🤖 Open Intelligence Dossier available for AI agents & citation View Markdown (.md) →
◼ Archived Business

Bon Secours nears $6bn takeover of Bain-backed Surgery Partners

Nonprofit Bon Secours Mercy Health is moving to acquire surgery center chain Surgery Partners in a deal valued at approximately $5.7 billion to $6 billion.

22sources
25articles
29velocity
+947%since first seen
22d agofirst detected

Velocity

How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →

📍 How it ended

Bon Secours Mercy Health affiliate HealthSpan agreed to a $5.7 billion take-private deal to acquire Surgery Partners. Following the announcement, Surgery Partners shares surged 46%.

Halper Sadeh LLC launched an investigation into whether shareholders were obtaining a fair price for the acquisition.

Epilogue added 20d ago, after coverage quieted.

The brief

Nonprofit healthcare provider Bon Secours Mercy Health, via its affiliate HealthSpan Partners, has reached an agreement to acquire the Brentwood-based surgery center chain Surgery Partners. The transaction, which is described as a take-private deal, is valued at $5.7 billion according to multiple reports, though some early coverage from the Financial Times, Bloomberg, and Yahoo Finance cited a figure nearing $6 billion. As part of the arrangement, Bain Capital affiliates, which currently hold a roughly 39% stake in Surgery Partners, will remain involved. The legal framework for the acquisition includes regulatory counsel provided by McGuireWoods to HealthSpan Partners. Financial outlets including the Wall Street Journal, Axios, and Modern Healthcare News have emphasized the shift of Surgery Partners from a public company to a private entity. The market reacted sharply to the news, with Proactive financial news reporting a 46% surge in shares, while Investing.com noted a 21% jump in premarket trading.

Yahoo Finance described the movement as the stock's best day in more than six years. Other outlets covering the move include the Nashville Post, which characterized Bon Secours as a Cincinnati giant, and qz.com, as well as PEI Private Equity, which focused on the continued role of Bain Capital. Contextual details reveal the complexities of the merger agreement and the scrutiny following the announcement. According to TradingView, Surgery Partners is required to pay a termination fee of $108.9 million to Spyglass Topco if the merger agreement is terminated under specific circumstances. The acquisition marks a significant expansion for the Bon Secours Mercy Health affiliate. Meanwhile, the deal has already drawn legal scrutiny; Business Wire reports that Halper Sadeh LLC is investigating whether the price being offered to Surgery Partners shareholders is fair, highlighting potential friction during the take-private process.

Future developments to monitor include the finalization of the $5.7 billion to $6 billion valuation and the outcome of the shareholder price investigation by Halper Sadeh LLC. Observers will also be tracking the regulatory approval process managed by McGuireWoods. The market will continue to watch the performance of SGRY stock on the NASDAQ as the deal progresses toward closing. Coverage from TradingView and various financial tickers suggests continued interest in how this acquisition impacts the broader surgery center landscape and the specific obligations owed to Spyglass Topco should the deal fail.

Synthesized by PULSE from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 20d ago.

Quick answers

What is the total value of the acquisition?

Most reports, including the Wall Street Journal and Axios, state the deal is valued at $5.7 billion, though the Financial Times and Bloomberg reported it as nearing $6 billion.

Who is providing regulatory counsel for the deal?

McGuireWoods is providing regulatory counsel to HealthSpan Partners for the acquisition of Surgery Partners.

What is the role of Bain Capital in this transaction?

Bain Capital affiliates, who hold a roughly 39% stake in Surgery Partners, are backing the deal and will stay on as part of the take-private agreement.

Coverage (25)

Topics

Related trends

\n \n \n \n \n \n \n